July 5, 2024
admin
Nephro Care India IPO GMP review & Subscription Status
👉 Chanakyanipothi.com, a legacy of 31 Years.
India`s Oldest Investment & IPO website.
👉Most Trusted by Investors across India.
Table of Contents
Nephro Care India IPO listing Review
Nephro Care India allotment
Anchor Investors: Prominent investors, including CCV Emerging Opportunities Fund – I, Persistent Growth Fund – Varsu India Growth Story Scheme 1 and Vikasa India EIF I Fund – Incube Global Opportunities participated in the anchor book subscription
· The company raises Rs. 11.14 crore from the sale of 12.38 Lakh equity shares with a face value of Rs. 10/- priced at Rs. 90/- per share
What is the latest Nephro Care India IPO Grey market premium?
Various parameters indicate high Nephro Care India IPO GMP. For latest GMP, Click
Subscription status of Nephro Care India IPO
|
Nephrocare India IPO Closing today Price Rs. 90 Lot 1600 shares |
||||
| QIB | NII X | RII X | Total X | Applications |
| 245.14 | 1787.19 | 634.12 | 715.78 | 5,72,611/ (634.12x) |
| Amount wise bids recd. Rs.28044.26 Crore | ||||
| Note: Very impressive subscriptions | ||||
What is the business of Nephro Care India ?
In December 2023, Nephro Care India Limited successfully closed the pre-IPO funding round, which saw the participation of banking veteran and former chairman of HDFC Ltd, Deepak Parekh, chairman of HDFC Securities Bharat Shah, and Rajendra Agarwal, Founder and MD of Macleods Pharmaceuticals, among others. Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients. As on date, Nephro Care is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. The operations of Nephro Care are supported by a pool of expert Doctors, experienced and well-trained paramedical professionals and a skilled
management team. The entire team at Nephro Care is supported by sufficient clinical and investigative infrastructure. At Nephro Care treatment regimes are planned and practiced on the basis of core scientific understanding, transparency and ethics. It is committed to providing the best medical care at an affordable cost to all our local, national and international patients.
Get more information about the company @ https://www.nephrocareindia.com/
Nephro Care India IPO Details |
|
| IPO opens on | 28 June 2024 |
| IPO closes on | 2 July 2024 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 4584000 Shares / Rs 41.26 Crore |
| * Fresh Issue | 4584000 Shares / Rs 41.26 Crore |
| * Offer for Sale – | |
| Market Maker Portion | 230400 Shares |
| Net offer to Public | 4353600 Shares/ Rs.39.18 Crore |
| Face Value per share | Rs. 10 |
| Price Band | Rs.85-90 |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | 1600 Shares |
| Listing will at | NSE SME |
Shares offered in IPO |
||
| Shares | Rs. (Crore) | |
| QIB (50%) | 2176800 | 19.59 |
| NII (15%) | 653040 | 5.88 |
| RII (35%) | 1523760 | 13.71 |
| Total Shares | 4353600 | 39.18 |
| Retail portion will be oversubscribed by | 952 | |
| Forms | ||
| How much Shares to Apply in this IPO? | ||
| Min Retail Application | 1600 Shares | Rs. 144000 |
| Min HNI Application | 3200 Shares | Rs.288000 |
Who is the Promoter of Nephro Care India IPO?
The company promoter is Dr. Pratim Sengupta.
What are the Objects of Nephro Care India IPO?
The Offer comprises of only fresh issue of shares.
The objectives of the Offer are to:
1.Setting up of Multi Speciality Hospital in the name of “Vivacity Multi Specialty Hospital” (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal; and
2.General Corporate Expenses
Tentative timetable |
|
| IPO opens on | 28 June 2024 |
| IPO Closes on | 2 July 2024 |
| IPO Allotment on | 3 July 2024 |
| Refund Initiation | 4 July 2024 |
| Credit of Shares | 4 July 2024 |
| Listing on | 5 July 2024 |
| Registered Office of the Company Nephro Care India Limited Flat No-1JC-18, 5th Floor Sec-III Salt lake Kolkata, Bidhan Nagar Sai Complex, North 24 Parganas -700098 |
| Who is the Lead Manager of this IPO? Corporate Capitalventures Pvt Ltd |
| Who is the Registrar to IPO? Bigshare Services Pvt Ltd |
Nephro Care India IPO Financial & Analytical Ratios |
||||
| Year | Total Income | Net Profit | EPS | RoNW |
| Rs.in Cr | Rs.in Crore | Rs. | % | |
| 2020-21 | 1.83 | 0.09 | 4.44 | 591.3 |
| 2021-22 | 3.43 | -0.01 | -0.03 | -1.98 |
| 2022-23 | 17.10 | 1.94 | 1.94 | 79.68 |
| Book Value of the Share on | 31.03.2023 | Rs 2.44 | ||
| BV of the Share at cap price | after the IPO | Rs. | ||
| Offer Price/upper band | Rs. 90 | |||
IPO
|
|
| Price/last EPS of 22-23 | 46.39 |
| Price/BV Ratio | 36.88 |
| Upper price/BV after IPO | – |
How Nephro Care India IPO compares with the Peers?
There are no listed companies in India that engage in a business similar to that of this Company. Accordingly, it is not possible to provide an industry comparison in relation to the Company.
| As on date of DRHP | FV | Total | PE |
| Rs. | Income | Ratio of | |
| Rs. In Cr | |||
# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Nephro Care India IPO Review
In December 2023, Nephro Care India Limited successfully closed the pre-IPO funding round, which saw the participation of banking veteran and former chairman of HDFC Ltd, Deepak Parekh, chairman of HDFC Securities Bharat Shah, and Rajendra Agarwal, Founder and MD of Macleods Pharmaceuticals, among others. Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients. As on date, Nephro Care is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients.
Size: Net size of the IPO is Rs. 39.18 crore, which is not very large, compared to other SME IPOs. The retail portion is Rs. 13.71 Crore and NII portion is Rs.5.88 Crore. Because of not so large size, huge oversubscription is possible.
Financial Snapshot: The company has shown sharp fluctuations in the topline and bottom-line during last 3 years. If we rely on the profit for the year 2022-23 and the performance for the 9 months ending 31 December 2023, the shares offer good scope for listing gains. Healthcare stocks are expected to catch investment fancy and in the past, healthcare ipos have received bumper oversubscriptions and listings. Apply.
Quicklinks
Nephro Care India IPO GMP today allotment, review?
Nephro Care India IPO
IPO FAQs
What is Nephro Care India IPO?
This is a SME IPO of 4584000 equity shares of the face value of Rs. 10 aggregating up to Rs.41.26 Crores. The issue is priced at Rs.85-90 per share. The minimum order quantity is 1600 Shares.
When will Nephro Care India IPO subscription open?
The IPO opens on June 28, 2024, and closes on July 2, 2024.
What is the lot size of Nephro Care India IPO?
The IPO lot size is 1600 Shares, and the minimum amount required is Rs.144000
How to apply for Nephro Care India IPO?
You can apply in this IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
When is Nephro Care India IPO allotment?
The finalization of Basis of Allotment for this IPO will be done on 3 July, 2024, and the allotted shares will be credited to your demat account by July 4, 2024.
When is Nephro Care India IPO listing date?
This IPO listing date is July 5, 2024.
